Image courtesy of Present Diabetes
By Russ Ward (@russcward)
Over the last couple of weeks, if you haven’t heard people talking about Avandia, GlaxoSmithKline’s diabetes drug, you must have been on that mythical desert island that people always talk about.
The FDA convened a hearing to discuss the drug – and specifically, to discuss the heart attacks that [...]
